DK1532986T3 - Farmaceutisk sammensætning til behandling af rhinitis - Google Patents

Farmaceutisk sammensætning til behandling af rhinitis

Info

Publication number
DK1532986T3
DK1532986T3 DK04024727.2T DK04024727T DK1532986T3 DK 1532986 T3 DK1532986 T3 DK 1532986T3 DK 04024727 T DK04024727 T DK 04024727T DK 1532986 T3 DK1532986 T3 DK 1532986T3
Authority
DK
Denmark
Prior art keywords
rhinitis
pharmaceutical composition
treatment
action
salts
Prior art date
Application number
DK04024727.2T
Other languages
English (en)
Inventor
Harald Greve
Rainer Greve
Original Assignee
Klosterfrau Mcm Vetrieb Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klosterfrau Mcm Vetrieb Gmbh filed Critical Klosterfrau Mcm Vetrieb Gmbh
Application granted granted Critical
Publication of DK1532986T3 publication Critical patent/DK1532986T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04024727.2T 2003-11-13 2004-10-16 Farmaceutisk sammensætning til behandling af rhinitis DK1532986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10353690 2003-11-13
DE10356248A DE10356248A1 (de) 2003-11-13 2003-12-02 Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden

Publications (1)

Publication Number Publication Date
DK1532986T3 true DK1532986T3 (da) 2010-04-06

Family

ID=31969799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04024727.2T DK1532986T3 (da) 2003-11-13 2004-10-16 Farmaceutisk sammensætning til behandling af rhinitis

Country Status (12)

Country Link
US (2) US20050107330A1 (da)
EP (1) EP1532986B1 (da)
JP (1) JP2005145963A (da)
AT (1) ATE451934T1 (da)
CY (1) CY1110289T1 (da)
DE (3) DE20318634U1 (da)
DK (1) DK1532986T3 (da)
ES (1) ES2336668T3 (da)
NO (1) NO333334B1 (da)
PL (1) PL1532986T3 (da)
PT (1) PT1532986E (da)
SI (1) SI1532986T1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0309890A (pt) * 2002-05-09 2005-05-10 Medigenes Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
DE102007052380A1 (de) 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
IT1396468B1 (it) * 2008-11-11 2012-12-14 Farma Derma Srl Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
ES2667854T3 (es) 2011-07-07 2018-05-14 Holy Stone Healthcare Co., Ltd. Composición para uso en el tratamiento y la prevención de trastornos relacionados con la inflamación
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
HUE025567T2 (en) * 2011-08-19 2016-02-29 Maria Clementine Martin Klosterfrau Vertriebsges Mbh Agents containing vasoconstrictors for combination therapy
DE102012005452A1 (de) 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
DE102012011447B4 (de) 2012-05-14 2022-11-24 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Verwendung von Pantothenol oder Pantothensäure in einem Kombinationstherapeutikum für die Behandlung von Rhinitis zur Verringerung der systemischen Resorption imidazolinbasierter alpha-Sympathomimetika
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
DE202014105553U1 (de) 2014-08-18 2015-08-20 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation
DE102015113802A1 (de) 2015-07-06 2017-01-12 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung von Rhinitis
DE102015115107A1 (de) 2015-09-01 2017-03-02 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige wässrige Zusammensetzung für die nasale Applikation
DE202017104738U1 (de) * 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
US20200246311A1 (en) * 2017-08-10 2020-08-06 Elixir Ilac Arastirma Ve Gelistirme A.S. Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate
EP4404916B1 (en) 2021-09-22 2025-08-06 JADRAN - GALENSKI LABORATORIJ d.d. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1087842A (en) 1963-05-01 1967-10-18 Leo Ab Nasal decongestive compositions
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
JPH0717870A (ja) 1993-06-29 1995-01-20 Toshiko Yamamoto トローチ剤
US5583120A (en) * 1993-08-04 1996-12-10 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
DE19541919C2 (de) * 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19549421C2 (de) 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE10064219B9 (de) 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
DK1363600T3 (da) * 2001-02-15 2009-01-26 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af mucosale sygdomme og lidelser
DE10161110A1 (de) 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
JP2005533076A (ja) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー ムコ多糖及びプロピレングリコールを含む鼻用組成物

Also Published As

Publication number Publication date
NO20044639L (no) 2005-05-18
JP2005145963A (ja) 2005-06-09
EP1532986A3 (de) 2005-07-20
ES2336668T3 (es) 2010-04-15
US20050107330A1 (en) 2005-05-19
US20110245202A1 (en) 2011-10-06
SI1532986T1 (sl) 2010-04-30
HK1080284A1 (zh) 2006-04-21
EP1532986A2 (de) 2005-05-25
PT1532986E (pt) 2010-02-18
PL1532986T3 (pl) 2010-05-31
DE502004010514D1 (de) 2010-01-28
DE10356248A1 (de) 2005-06-23
DE20318634U1 (de) 2004-02-26
NO333334B1 (no) 2013-05-06
ATE451934T1 (de) 2010-01-15
EP1532986B1 (de) 2009-12-16
CY1110289T1 (el) 2015-01-14

Similar Documents

Publication Publication Date Title
CY1110289T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια ρινιτιδων
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
ATE401865T1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
IS7840A (is) 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
DK1385519T3 (da) Tiotropiumsalte til behandling af inflammatoriske sygdomme
NO20051726L (no) Pyrimidinonderivaer som terapeutiske midler ovenfor akutte og kroniske inflammasjons-, iskemiske og remodeleringsprosesser
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
BR0109703A (pt) Derivados de piperazina
SE0101932D0 (sv) Pharmaceutical combinations
NO20050662L (no) COX-2 inhiberende pyridinderivater
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
CY1112173T1 (el) Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας
BR0314844A (pt) Novo composto
BR0314843A (pt) Novo composto
HRP20050439B1 (hr) Nova upotreba dekstran sulfata
PT1150704E (pt) Melagatran para o tratamento da inflamacao
SE0200198D0 (sv) New use
DE60305053D1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
ATE343576T1 (de) 7-azaindolderivate als cox2-inhibitoren
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
SE0300535D0 (sv) Treatment of burns